Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 707

1.

Barriers and facilitators for individualized rehabilitation during breast cancer treatment - a focus group study exploring health care professionals' experiences.

Olsson Möller U, Olsson IM, Sjövall K, Beck I, Rydén L, Malmström M.

BMC Health Serv Res. 2020 Mar 26;20(1):252. doi: 10.1186/s12913-020-05107-7.

2.

Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries.

Kotseva K, De Backer G, De Bacquer D, Rydén L, Hoes A, Grobbee D, Maggioni A, Marques-Vidal P, Jennings C, Abreu A, Aguiar C, Badariene J, Bruthans J, Cifkova R, Davletov K, Dilic M, Dolzhenko M, Gaita D, Gotcheva N, Hasan-Ali H, Jankowski P, Lionis C, Mancas S, Milićić D, Mirrakhimov E, Oganov R, Pogosova N, Reiner Ž, Vulić D, Wood D.

Eur J Prev Cardiol. 2020 Mar 20:2047487320908698. doi: 10.1177/2047487320908698. [Epub ahead of print]

PMID:
32195597
3.

Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer.

Larsson AM, Bendahl PO, Aaltonen K, Jansson S, Forsare C, Bergqvist M, Jørgensen CLT, Rydén L.

Sci Rep. 2020 Mar 11;10(1):4484. doi: 10.1038/s41598-020-61416-1.

4.

Prevalence of hearing loss and need for aural rehabilitation in 85-year-olds: a birth cohort comparison, almost three decades apart.

Göthberg H, Rosenhall U, Tengstrand T, Rydén L, Wetterberg H, Skoog I, Sadeghi A.

Int J Audiol. 2020 Mar 4:1-10. doi: 10.1080/14992027.2020.1734878. [Epub ahead of print]

PMID:
32129119
5.

Proceedings of the Guideline Workshop 2019 - Strategies for the optimization of guideline processes in diabetes, cardiovascular diseases and kidney diseases.

Marx N, Rydén L, Brosius F, Ceriello A, Cheung M, Cosentino F, Green J, Kellerer M, Koob S, Kosiborod M, Nedungadi P, Rodbard HW, Vandvik PO, Standl E, Schnell O.

Diabetes Res Clin Pract. 2020 Feb 26;162:108092. doi: 10.1016/j.diabres.2020.108092. [Epub ahead of print]

PMID:
32109519
6.

Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease-A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V.

Ferrannini G, De Bacquer D, De Backer G, Kotseva K, Mellbin L, Wood D, Rydén L; EUROASPIRE V collaborators.

Diabetes Care. 2020 Apr;43(4):726-733. doi: 10.2337/dc19-2165. Epub 2020 Feb 20.

PMID:
32079627
7.

The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer.

de Boniface J, Ahlgren J, Andersson Y, Bergkvist L, Frisell J, Lundstedt D, Olofsson Bagge R, Rydén L, Sund M; SENOMAC Trialists’ Group.

Breast Cancer Res Treat. 2020 Feb;180(1):167-176. doi: 10.1007/s10549-020-05537-1. Epub 2020 Jan 27.

8.

NFC Powered Implantable Temperature Sensor.

Kifle Y, Wikner JJ, Zotterman J, Ryden L, Farnebo S.

Conf Proc IEEE Eng Med Biol Soc. 2019 Jul;2019:4359-4362. doi: 10.1109/EMBC.2019.8856607.

PMID:
31946833
9.

The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial.

Gerstein HC, Hart R, Colhoun HM, Diaz R, Lakshmanan M, Botros FT, Probstfield J, Riddle MC, Rydén L, Atisso CM, Dyal L, Hall S, Avezum A, Basile J, Conget I, Cushman WC, Hancu N, Hanefeld M, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Muñoz EGC, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T.

Lancet Diabetes Endocrinol. 2020 Feb;8(2):106-114. doi: 10.1016/S2213-8587(19)30423-1. Epub 2020 Jan 7.

PMID:
31924562
10.

Response to Comment on Norhammar et al. Undetected Dysglycemia Is an Important Risk Factor for Two Common Diseases, Myocardial Infarction and Periodontitis: A Report From the PAROKRANK Study. Diabetes Care 2019;42:1504-1511.

Norhammar A, Kjellström B, Habib N, Gustafsson A, Klinge B, Nygren Å, Näsman P, Svenungsson E, Rydén L.

Diabetes Care. 2020 Jan;43(1):e9. doi: 10.2337/dci19-0055. No abstract available.

PMID:
31862825
11.

Investigation of antihypertensive class, dementia, and cognitive decline: A meta-analysis.

Peters R, Yasar S, Anderson CS, Andrews S, Antikainen R, Arima H, Beckett N, Beer JC, Bertens AS, Booth A, van Boxtel M, Brayne C, Brodaty H, Carlson MC, Chalmers J, Corrada M, DeKosky S, Derby C, Dixon RA, Forette F, Ganguli M, van Gool WA, Guaita A, Hever AM, Hogan DB, Jagger C, Katz M, Kawas C, Kehoe PG, Keinanen-Kiukaanniemi S, Kenny RA, Köhler S, Kunutsor SK, Laukkanen J, Maxwell C, McFall GP, van Middelaar T, Moll van Charante EP, Ng TP, Peters J, Rawtaer I, Richard E, Rockwood K, Rydén L, Sachdev PS, Skoog I, Skoog J, Staessen JA, Stephan BCM, Sebert S, Thijs L, Trompet S, Tully PJ, Tzourio C, Vaccaro R, Vaaramo E, Walsh E, Warwick J, Anstey KJ.

Neurology. 2020 Jan 21;94(3):e267-e281. doi: 10.1212/WNL.0000000000008732. Epub 2019 Dec 11.

PMID:
31827004
12.

Glucose-lowering therapies in patients with type 2 diabetes and cardiovascular diseases.

Prattichizzo F, La Sala L, Rydén L, Marx N, Ferrini M, Valensi P, Ceriello A.

Eur J Prev Cardiol. 2019 Dec;26(2_suppl):73-80. doi: 10.1177/2047487319880040.

PMID:
31766918
13.

The metabolic syndrome - What is it and how should it be managed?

Nilsson PM, Tuomilehto J, Rydén L.

Eur J Prev Cardiol. 2019 Dec;26(2_suppl):33-46. doi: 10.1177/2047487319886404.

PMID:
31766917
14.

Risk and management of pre-diabetes.

Beulens J, Rutters F, Rydén L, Schnell O, Mellbin L, Hart HE, Vos RC.

Eur J Prev Cardiol. 2019 Dec;26(2_suppl):47-54. doi: 10.1177/2047487319880041.

PMID:
31766914
15.

Risk factor reduction in type 2 diabetes demands a multifactorial approach.

Rydén L, Ferrannini G, Mellbin L.

Eur J Prev Cardiol. 2019 Dec;26(2_suppl):81-91. doi: 10.1177/2047487319872015.

PMID:
31766912
16.

Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications.

Dal Canto E, Ceriello A, Rydén L, Ferrini M, Hansen TB, Schnell O, Standl E, Beulens JW.

Eur J Prev Cardiol. 2019 Dec;26(2_suppl):25-32. doi: 10.1177/2047487319878371. Epub 2019 Nov 13.

PMID:
31722562
17.

Associations among Periodontitis, Calcified Carotid Artery Atheromas, and Risk of Myocardial Infarction.

Gustafsson N, Ahlqvist J, Näslund U, Buhlin K, Gustafsson A, Kjellström B, Klinge B, Rydén L, Levring Jäghagen E.

J Dent Res. 2020 Jan;99(1):60-68. doi: 10.1177/0022034519885362. Epub 2019 Nov 8.

PMID:
31702950
18.

Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study.

Staaf J, Glodzik D, Bosch A, Vallon-Christersson J, Reuterswärd C, Häkkinen J, Degasperi A, Amarante TD, Saal LH, Hegardt C, Stobart H, Ehinger A, Larsson C, Rydén L, Loman N, Malmberg M, Kvist A, Ehrencrona H, Davies HR, Borg Å, Nik-Zainal S.

Nat Med. 2019 Oct;25(10):1526-1533. doi: 10.1038/s41591-019-0582-4. Epub 2019 Sep 30.

19.

Bleeding and New Cancer Diagnosis in Patients With Atherosclerosis.

Eikelboom JW, Connolly SJ, Bosch J, Shestakovska O, Aboyans V, Alings M, Anand SS, Avezum A, Berkowitz SD, Bhatt DL, Cook-Bruns N, Felix C, Fox KAA, Hart RG, Maggioni AP, Moayyedi P, O'Donnell M, Rydén L, Verhamme P, Widimsky P, Zhu J, Yusuf S.

Circulation. 2019 Oct 29;140(18):1451-1459. doi: 10.1161/CIRCULATIONAHA.119.041949. Epub 2019 Sep 12.

PMID:
31510769
20.

Percentage low-density lipoprotein-cholesterol response to a given statin dose is not fixed across the pre-treatment range: Real world evidence from clinical practice: Data from the ESC-EORP EUROASPIRE V Study.

Bacquer D, Smedt D, Reiner Ž, Tokgözoğlu L, Clays E, Kotseva K, Rydén L, Wood D, Backer G.

Eur J Prev Cardiol. 2019 Sep 9:2047487319874898. doi: 10.1177/2047487319874898. [Epub ahead of print]

PMID:
31500460
21.

Dizziness and its association with walking speed and falls efficacy among older men and women in an urban population.

Lindell E, Kollén L, Johansson M, Karlsson T, Rydén L, Zettergren A, Frändin K, Skoog I, Finizia C.

Aging Clin Exp Res. 2019 Sep 5. doi: 10.1007/s40520-019-01303-6. [Epub ahead of print]

PMID:
31489596
22.

A Roadmap on the Prevention of Cardiovascular Disease Among People Living With Diabetes.

Mitchell S, Malanda B, Damasceno A, Eckel RH, Gaita D, Kotseva K, Januzzi JL, Mensah G, Plutzky J, Prystupiuk M, Ryden L, Thierer J, Virani SS, Sperling L.

Glob Heart. 2019 Sep;14(3):215-240. doi: 10.1016/j.gheart.2019.07.009. No abstract available.

PMID:
31451236
23.

Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series.

Vallon-Christersson J, Häkkinen J, Hegardt C, Saal LH, Larsson C, Ehinger A, Lindman H, Olofsson H, Sjöblom T, Wärnberg F, Ryden L, Loman N, Malmberg M, Borg Å, Staaf J.

Sci Rep. 2019 Aug 21;9(1):12184. doi: 10.1038/s41598-019-48570-x.

24.

Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer.

Lundgren C, Bendahl PO, Borg Å, Ehinger A, Hegardt C, Larsson C, Loman N, Malmberg M, Olofsson H, Saal LH, Sjöblom T, Lindman H, Klintman M, Häkkinen J, Vallon-Christersson J, Fernö M, Rydén L, Ekholm M.

Breast Cancer Res Treat. 2019 Nov;178(2):459-467. doi: 10.1007/s10549-019-05378-7. Epub 2019 Aug 20.

25.

Prediction of Lymph Node Metastasis in Breast Cancer by Gene Expression and Clinicopathological Models: Development and Validation within a Population-Based Cohort.

Dihge L, Vallon-Christersson J, Hegardt C, Saal LH, Häkkinen J, Larsson C, Ehinger A, Loman N, Malmberg M, Bendahl PO, Borg Å, Staaf J, Rydén L.

Clin Cancer Res. 2019 Nov 1;25(21):6368-6381. doi: 10.1158/1078-0432.CCR-19-0075. Epub 2019 Jul 24.

PMID:
31340938
27.

Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment.

Förnvik D, Aaltonen KE, Chen Y, George AM, Brueffer C, Rigo R, Loman N, Saal LH, Rydén L.

Breast Cancer Res Treat. 2019 Sep;177(2):447-455. doi: 10.1007/s10549-019-05326-5. Epub 2019 Jun 24.

28.

Artificial neural network models to predict nodal status in clinically node-negative breast cancer.

Dihge L, Ohlsson M, Edén P, Bendahl PO, Rydén L.

BMC Cancer. 2019 Jun 21;19(1):610. doi: 10.1186/s12885-019-5827-6.

29.

Agreement between self-reports, proxy-reports and the National Patient Register regarding diagnoses of cardiovascular disorders and diabetes mellitus in a population-based sample of 80-year-olds.

Rydén L, Sigström R, Nilsson J, Sundh V, Falk Erhag H, Kern S, Waern M, Östling S, Wilhelmson K, Skoog I.

Age Ageing. 2019 Jul 1;48(4):513-518. doi: 10.1093/ageing/afz033.

30.

Refinement of breast cancer molecular classification by miRNA expression profiles.

Søkilde R, Persson H, Ehinger A, Pirona AC, Fernö M, Hegardt C, Larsson C, Loman N, Malmberg M, Rydén L, Saal L, Borg Å, Vallon-Christerson J, Rovira C.

BMC Genomics. 2019 Jun 17;20(1):503. doi: 10.1186/s12864-019-5887-7.

31.

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.

Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators.

Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9.

PMID:
31189511
32.

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.

Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators.

Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9.

PMID:
31189509
33.

Undetected Dysglycemia Is an Important Risk Factor for Two Common Diseases, Myocardial Infarction and Periodontitis: A Report From the PAROKRANK Study.

Norhammar A, Kjellström B, Habib N, Gustafsson A, Klinge B, Nygren Å, Näsman P, Svenungsson E, Rydén L.

Diabetes Care. 2019 Aug;42(8):1504-1511. doi: 10.2337/dc19-0018. Epub 2019 Jun 10.

PMID:
31182493
34.

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.

Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH, Bhatt DL, Verhamme PB, O'Donnell M, Maggioni AP, Lonn EM, Piegas LS, Ertl G, Keltai M, Bruns NC, Muehlhofer E, Dagenais GR, Kim JH, Hori M, Steg PG, Hart RG, Diaz R, Alings M, Widimsky P, Avezum A, Probstfield J, Zhu J, Liang Y, Lopez-Jaramillo P, Kakkar AK, Parkhomenko AN, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Vinereanu D, Tonkin AM, Lewis BS, Felix C, Yusoff K, Metsarinne KP, Fox KAA, Yusuf S; COMPASS Investigators.

Gastroenterology. 2019 Sep;157(3):682-691.e2. doi: 10.1053/j.gastro.2019.05.056. Epub 2019 May 29.

PMID:
31152740
35.

A comprehensive approach to rehabilitation interventions following breast cancer treatment - a systematic review of systematic reviews.

Olsson Möller U, Beck I, Rydén L, Malmström M.

BMC Cancer. 2019 May 20;19(1):472. doi: 10.1186/s12885-019-5648-7.

36.

Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial.

Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH, Bhatt DL, Verhamme PB, O'Donnell M, Maggioni AP, Lonn EM, Piegas LS, Ertl G, Keltai M, Cook Bruns N, Muehlhofer E, Dagenais GR, Kim JH, Hori M, Steg PG, Hart RG, Diaz R, Alings M, Widimsky P, Avezum A, Probstfield J, Zhu J, Liang Y, Lopez-Jaramillo P, Kakkar A, Parkhomenko AN, Ryden L, Pogosova N, Dans A, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik T, Vinereanu D, Tonkin AM, Lewis BS, Felix C, Yusoff K, Metsarinne K, Fox KAA, Yusuf S; COMPASS Investigators.

Gastroenterology. 2019 Aug;157(2):403-412.e5. doi: 10.1053/j.gastro.2019.04.041. Epub 2019 May 2.

PMID:
31054846
37.

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries.

De Backer G, Jankowski P, Kotseva K, Mirrakhimov E, Reiner Ž, Rydén L, Tokgözoğlu L, Wood D, De Bacquer D; EUROASPIRE V collaborators; Writing Committee; Scientific Steering/ Executive Committee; Coordinating centre; Diabetes centre; Data management centre; Statistical analysis centre; Central laboratory; Study centres, organisations, investigators and other research personnel (National Co-ordinators in each country are indicated by asterisk.

Atherosclerosis. 2019 Jun;285:135-146. doi: 10.1016/j.atherosclerosis.2019.03.014. Epub 2019 Apr 24.

PMID:
31054483
38.

Epidemiology of suicidal feelings in an ageing Swedish population: from old to very old age in the Gothenburg H70 Birth Cohort Studies.

Fässberg MM, Vanaelst B, Jonson M, Sterner TR, Ahlner F, Wetterberg H, Rydén L, Kern S, Sigström R, Zettergren A, Skoog I, Waern M.

Epidemiol Psychiatr Sci. 2019 Apr 1;29:e26. doi: 10.1017/S2045796019000143.

PMID:
30929647
39.

Atrial fibrillation increases the risk of dementia amongst older adults even in the absence of stroke.

Rydén L, Zettergren A, Seidu NM, Guo X, Kern S, Blennow K, Zetterberg H, Sacuiu S, Skoog I.

J Intern Med. 2019 Jul;286(1):101-110. doi: 10.1111/joim.12902. Epub 2019 Apr 22.

PMID:
30895641
40.

The Medical Profession, Industry, and Continuing Medical Education: Finding the Balance That's Right for Patients.

Kearney P, Simoons M, Ryden L, Kirchhof P, Pries A, O'Morain C, Bax JJ.

Am J Med. 2019 Aug;132(8):921-925. doi: 10.1016/j.amjmed.2019.02.026. Epub 2019 Mar 8. Review.

PMID:
30853472
41.

Clinical implications of cardiovascular outcome trials in type 2 diabetes.

Mellbin LG, Wang A, Rydén L.

Herz. 2019 May;44(3):192-202. doi: 10.1007/s00059-019-4789-4.

42.

The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast.

Narbe U, Sjöström M, Forsare C, Bendahl PO, Alkner S, Leeb-Lundberg LMF, Lövgren K, Rydén L, Ingvar C, Fernö M.

Breast Cancer Res Treat. 2019 Jun;175(2):305-316. doi: 10.1007/s10549-019-05138-7. Epub 2019 Feb 22.

43.

Effects of adjuvant tamoxifen over three decades on breast cancer-free and distant recurrence-free interval among premenopausal women with oestrogen receptor-positive breast cancer randomised in the Swedish SBII:2pre trial.

Ekholm M, Bendahl PO, Fernö M, Nordenskjöld B, Stål O, Rydén L; South Swedish and South-East Swedish Breast Cancer Groups.

Eur J Cancer. 2019 Mar;110:53-61. doi: 10.1016/j.ejca.2018.12.034. Epub 2019 Feb 12.

44.

Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry.

Kotseva K, De Backer G, De Bacquer D, Rydén L, Hoes A, Grobbee D, Maggioni A, Marques-Vidal P, Jennings C, Abreu A, Aguiar C, Badariene J, Bruthans J, Castro Conde A, Cifkova R, Crowley J, Davletov K, Deckers J, De Smedt D, De Sutter J, Dilic M, Dolzhenko M, Dzerve V, Erglis A, Fras Z, Gaita D, Gotcheva N, Heuschmann P, Hasan-Ali H, Jankowski P, Lalic N, Lehto S, Lovic D, Mancas S, Mellbin L, Milicic D, Mirrakhimov E, Oganov R, Pogosova N, Reiner Z, Stöerk S, Tokgözoğlu L, Tsioufis C, Vulic D, Wood D; EUROASPIRE Investigators*.

Eur J Prev Cardiol. 2019 May;26(8):824-835. doi: 10.1177/2047487318825350. Epub 2019 Feb 10.

45.

Chronic Myocardial Injury and Risk for Stroke.

Rydén L, Roos A, Holzmann MJ.

Am J Med. 2019 Jul;132(7):833-839. doi: 10.1016/j.amjmed.2019.01.027. Epub 2019 Feb 2.

PMID:
30716296
46.

Attitudes and lifestyle factors in relation to oral health and dental care in Sweden: a cross-sectional study.

Naimi-Akbar A, Kjellström B, Rydén L, Rathnayake N, Klinge B, Gustafsson A, Buhlin K.

Acta Odontol Scand. 2019 May;77(4):282-289. doi: 10.1080/00016357.2018.1539238. Epub 2019 Jan 11.

PMID:
30632867
47.

Testosterone, sex hormone-binding globulin and risk of cardiovascular events: A report from the Outcome Reduction with an Initial Glargine Intervention trial.

Wang A, Arver S, Boman K, Gerstein HC, Fu Lee S, Hess S, Rydén L, Mellbin LG.

Eur J Prev Cardiol. 2019 May;26(8):847-854. doi: 10.1177/2047487318819142. Epub 2018 Dec 19.

PMID:
30567457
48.

Parkinson's Disease in the Era of Personalised Medicine: One Size Does Not Fit All.

Ryden LE, Lewis SJG.

Drugs Aging. 2019 Feb;36(2):103-113. doi: 10.1007/s40266-018-0624-5.

PMID:
30556112
49.

Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer.

Forsare C, Bak M, Falck AK, Grabau D, Killander F, Malmström P, Rydén L, Stål O, Sundqvist M, Bendahl PO, Fernö M.

BMC Cancer. 2018 Dec 7;18(1):1226. doi: 10.1186/s12885-018-5123-x.

50.

Addressing cardiovascular risk in type 2 diabetes mellitus: a report from the European Society of Cardiology Cardiovascular Roundtable.

Cosentino F, Ceriello A, Baeres FMM, Fioretto P, Garber A, Stough WG, George JT, Grant PJ, Khunti K, Langkilde AM, Plutzky J, Rydén L, Scheen A, Standl E, Tuomilehto J, Zannad F.

Eur Heart J. 2019 Sep 7;40(34):2907-2919. doi: 10.1093/eurheartj/ehy677. No abstract available.

PMID:
30445605

Supplemental Content

Support Center